Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Upadacitinib effectively treated severe hair loss in a child.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.